Boots pauses home delivery of injectable weight loss medicines during the current heatwave, saying it is stopping shipments to protect the drugs in transit. The pharmacy chain makes the change to ensure the treatments remain within required temperature conditions while being transported to customers.
Both outlets report that injectable products such as Wegovy and Mounjaro require storage below 8C to maintain quality and effectiveness. During periods of high temperatures, deliveries may not be able to reliably meet these specifications, so Boots temporarily halts the service. The decision reflects the practical challenges of cold-chain requirements for medication shipped to homes.
While the reporting aligns on the reason—temperature control—each outlet frames the issue slightly differently. One describes the pause as a precaution to keep medication safe, while the other emphasizes that the halt is effectively required to maintain proper storage conditions. Neither outlet indicates a permanent change to the medicines themselves, describing the interruption as linked to weather and delivery conditions.
